Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor
✍ Scribed by Muna H. Abdi; Paul J. Beswick; Andy Billinton; Laura J. Chambers; Andrew Charlton; Sue D. Collins; Katharine L. Collis; David K. Dean; Elena Fonfria; Robert J. Gleave; Clarisse L. Lejeune; David G. Livermore; Stephen J. Medhurst; Anton D. Michel; Andrew P. Moses; Lee Page; Sadhana Patel; Shilina A. Roman; Stefan Senger; Brian Slingsby; Jon G.A. Steadman; Alexander J. Stevens; Daryl S. Walter
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 720 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
A computational lead-hopping exercise identified compound 4 as a structurally distinct P2X(7) receptor antagonist. Structure-activity relationships (SAR) of a series of pyroglutamic acid amide analogues of 4 were investigated and compound 31 was identified as a potent P2X(7) antagonist with excellent in vivo activity in animal models of pain, and a profile suitable for progression to clinical studies.
📜 SIMILAR VOLUMES
Structure-activity relationships (SAR) of analogues of lead compound 1 were investigated and compound 16 was selected for further study in animal models of pain. Compound 16 was shown to be a potent antihyperalgesic agent in both the rat acute complete Freund's adjuvant (CFA) model of inflammatory p